An attempt was made to change the specificity of antibodies (Abs) by introduction of mutations. A monoclonal Ab specific for 17α-hydroxyprogesterone (17-OHP) was used as the starting Ab. On the basis of a model that was generated by a computer-driven model-building system, we constructed a phage-display library of Abs in which 16 residues were mutated in three complementarity-determining regions of the heavy chain that appeared to form the steroid-binding pocket. We screened the library with 17-OHP and cortisol that had been conjugated with bovine serum albumin, and we isolated many clones that had retained 17-OHP-binding ability as well as clones with the newly developed ability to bind cortisol in addition to 17-OHP. We compared the amino acid sequences between 17-OHP-specific and cortisol-binding Abs, and then constructed several additional Abs. Our results indicated that a change in specificity could be achieved by changing only a single, critical amino acid residue. Models of the 17-OHPand cortisol-binding pockets formed by the mutated Abs could explain these observations.
Introduction
The antigen (Ag) specificity of antibodies (Abs) is determined primarily by the amino acid residues that form the Ag-binding site (Davies et al., 1990) . Six complementarity-determining regions (CDRs) in the variable (V) domains of the heavy (H) and light (L) antibody chains form the Ag-binding site (Chothia and Lesk, 1987) . Using this information, we have been constructing libraries of artificial Abs in which strongly diverged sequences are introduced into the six CDRs, while the amino acid sequences of the other regions, designated frameworks, are kept constant Ito and Kurosawa, 1994; . In a previous study , we constructed expression vectors that allowed the simultaneous introduction of highly diverged sequences into the six CDRs by the polymerase chain reaction (PCR) with degenerate oligodeoxynucleotide primers. Using this system, we have attempted to change the Ag specificity of Abs and to investigate the kinetic rules that underlie the determination of specificity.
Sawada and co-workers (Hosoda et al., 1986; Sawada et al., 1987) established six monoclonal Abs (mAbs) specific for 17α-hydroxyprogesterone (17-OHP) and one mAb specific for 11-deoxycortisol (11-DOC), while Stura et al. (1987) developed two mAbs specific for progesterone. The sequences of V H domains were encoded by V H genes that were classified to family 3 (four cases), family 9 (four cases) and family 1 (one case), as summarized in Table I . Although these mAbs crossreacted with various steroid derivatives, many of them did not cross-react or exhibited very low cross-reactivity with cortisol (Hosoda et al., 1986; Sawada et al., 1987; Hosoda et al., 1987) . In this study, we attempted to change the Ag specificity of mAb 1E9, a monoclonal antibody specific for 17-OHP that does not bind cortisol . In cortisol there are hydroxy groups at the 11th and 21st carbons of the steroid rings that are not present in 17-OHP, as shown in Figure 1 .
We used the following strategies to achieve our goal: (i) structural modelling of the Ag-binding pocket; (ii) expression of the Fab form of Ab using a phage-display system; (iii) introduction of mutated amino acids at positions in V H CDRs that might be involved in formation of the Ag-binding pocket; (iv) selection of clones by panning with cortisol-conjugated bovine serum albumin (BSA); (v) construction of several additional Abs by site-directed mutagenesis; and (vi) kinetic analysis of Ag-Ab interactions. From the library that we constructed, we isolated clones for Abs with the newly developed ability to bind cortisol in addition to 17-OHP.
Materials and methods

Antigens
Cortisol 3-(O-carboxymethyl)oxime (3-CMO) conjugated with BSA, designated CS-BSA, and 17-OHP 3-CMO conjugated with BSA, designated 17-OHP-BSA, were purchased from Sigma. Cortisol 3-CMO, 17-OHP 3-CMO and hen egg-white lysozyme (HEL) were also purchased from Sigma. Cortisol 3-CMO and 17-OHP 3-CMO were conjugated to HEL in 0.1 M potassium phosphate buffer (pH 6.0) as described previously (Hosoda et al., 1979) , and the products were designated CS-HEL and 17-OHP-HEL, respectively.
Oligonucleotide primers
The following oligonucleotides were synthesized chemically and used as primers for construction of plasmid DNAs.
Primer
Sequence Restriction site (underlined)
Construction of plasmid DNA that encoded mAb 1E9 Plasmid pAALFabD1.3mHL, described in a previous report , was modified as follows. The CAA codon at the 5th residue of the V H gene was changed from CTGCAA to CTGCAG generating a PstI site. The CTG codon at the 104th residue of the V L gene was changed from CTGGAG to CTCGAG generating a XhoI site. mRNA was prepared from 1E9 cells and cDNA was synthesized by reverse transcriptase. Nucleotide sequences encoding mAb 1E9 were described in a previous paper (Sawada et al., 1991) . Using two sets of primers, E9HPst plus E9HBst and E9LSac plus E9LXho, and the cDNA, we amplified by PCR the V H and Vκ genes, respectively, that encoded V regions of mAb 1E9. After digestion with appropriate restriction enzymes, the V H and Vκ genes were inserted into the modified pAALFabD1.3mHL plasmid. The resulting plasmid, designated pFCA-E9HL, was used in the following experiments. pFA-E9HL was the product of digestion of pFCA-E9HL with SalI and subsequent selfligation . Name  CDR1  CDR2  CDR3   31 35a  48 52a  60  95 100abcijk  AN02  SDYAWNW  WMGYMS-YSGSTRYNPSLRS  GWPLA--------Y   VH3 family  1E9  NNHAWNW  WMGYIS-YSGRTGYNPSLRG  GNSGR----YVMDF  138  SYSAWNW  WMGYIS-YSGGTGYNPSLKS  GSSYS----YAMDY  7D7  SDHVWNW  WMGYIN-YRGGTGYNPSLKS  GNRYY----YAMDY  57  SDHVWNW  WMAYIT-YSGSIGYNPSLTS  GNSLY----YAMDY   VH 9 family  DB3  NYGVN-W  WMGWINIYTGEPTYVDDFKG  GDYVN----WYFDV  11/32  NYGVN-W  WMGWINTYNGKPTYTDDFKG  GDYYN----WYLDY  SCET  NYGMN-W  WMDWINTYTGEPTYADDFKG  GNVRV----YAMDY  4B2  NYGMN-W  WMAWINTETGEPTYAEEFKG  EVRRL----YAMDY   VH1 family  101  GYVMN-W  WIGFINPYTGVTGYNQKFKA  GGLRR----YAMDY Sequences within VH-CDRs of Abs are aligned. CDR1 and CDR2 in the Table include parts of the second framework region: residues 36 and 47-49. Numbering of amino acid residues follows that of Kabat et al. (1991) (Leahy et al., 1988) . Antibodies 1E9, 138, 7D7, 57, 4B2 and 101 are antibodies specific for 17-OHP . Antibodies DB3 and 11/32 are antibodies specific for progesterone (Stura et al., 1987) . Antibody SCET is an antibody specific for 11-DOC (Hosoda et al., 1986) .
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Structural modelling of mAb 1E9
The proteins were represented by nonbonded parameters for the cell multipole method (Greengard and Rokhlin, 1987; Schmidt and Lee, 1991; Ding et al., 1992) , including the all-atom parameters from the CVFF force field (DauberOsguthorpe et al., 1988) . The simulations were initiated by adding the necessary hydrogen atoms to the crystal structure, using the Biopolymer module of InsightII 95.0 (Molecular Simulations Inc., San Diego, CA). To construct the model of the 1E9 molecule on the basis of sequence alignment, we used the V H domain of a murine mAb Fab fragment, AN02, whose crystal structure was obtained from the Brookhaven Protein Data Bank [entry 1BAF (Brünger et al., 1991) ] as the backbone of the model V H domain, apart from the region N96 to Y100i (where N96 is the asparagine at the 96th residue). The latter backbone was constructed from the corresponding region of the V H fragment of a progesterone-binding mAb, DB3 [entry 1DBB in the Brookhaven Protein Data Bank (Arevalo et al., 1993a and b) ]. To add the extra region of 1DBB to the backbone of 1BAF, we used six conserved residues (C22, W36, Y59, T73, D86 and W103), which were more than 10 residues apart, as reference points for a structural alignment, and 1BAF was superimposed on 1DBB. The extra region of 1DBB, D96 to W100i, was then added by replacing the structurally equivalent residue, W96, of 1BAF. After constructing the backbone, we replaced the side chains using the Biopolymer module of InsightII 95.0. The V L domain was constructed in the same way as the V H domain with 1BAF as the template. The backbone of region S27a-R27d was built by reference to the corresponding region of 1DBB, S27a-H27d, with subsequent replacement of the side chains. The models of mutant molecules were constructed in a similar way to the model of the 1E9 molecule. We postulated that 17-OHP and cortisol had been conjugated with BSA or HEL through amino groups of the side chains of lysine or arginine residues at the surface of the respective proteins. However, to simplify calculations in our modelling, modified 17-OHP and cortisol molecules, designated 17-OHP-KS and CS-KS, respectively, were substituted for 17-OHP and cortisol conjugated to proteins. 17-OHP-KS and CS-KS, in which oxygen atoms of the 3-keto group are replaced by ϭN-O-CH 2 -CO-NH-CH 2 -CH 2 -CH 2 -CH 3 , resemble 17-OHP-CMO and CS-CMO with side chains of lysine residues. As the initial starting arrangement for simulations, 17-OHP-KS and CS-KS were put on the same position as progesterone, which is the antigen recognized by 1DBB, in the crystal structure (Arevalo et al., 1993a,b) .
The systems were energy-minimized in vacuo with no restraint to remove any overlap of atoms that resulted from the alterations described above. The systems obtained were then equilibrated through 5 pico seconds (ps) of NVT-molecular dynamics at 298 K, in which only residues within 3 Å of mutated residues were allowed to move. The program Discover 3.0.0 (Molecular Simulations) was used for energy minimization and molecular dynamic calculations.
Construction of a library of 1E9-derived Abs that had been mutated in the three CDRs of the V H domain
Our strategy for construction of the library is depicted in Figure 2 . pFCA-E9HL was used as the template for PCRs. The product of PCR with primers E9HPst and E9H1b was digested with PstI and BamHI and inserted into pFCA-E9HL to generate pFCA-E9HlibIL. Since introduction of a codon for Trp (TGG) and codons for Tyr (TAT/C) at the same site without a termination codon was impossible with our protocol (Ito and Kurosawa, 1994) , we performed two separate PCRs. Equal amounts of products obtained with primers E9H2a and E9H2bY and with primers E9H2a and E9H2bW were mixed and digested with BamHI and BstPI, and fragments were inserted into pFCA-E9HL to generate pFCA-E9HlibIIL. Then 232-base pair (bp) fragments were prepared by digestion of pFCA-E9HlibIIL with BamHI and BstPI and inserted into pFCA-E9HlibIL. The resulting library, designated pFCAE9HlibL, was used for further analysis. Affinity selection Selection of phages with the ability to bind CS-BSA or 17-OHP-BSA was performed by panning, as described previously , with the exception that immunotubes were used instead of immunoplates and the surfaces were coated with 5 µg/ml CS-BSA or 17-OHP-BSA in phosphate-buffered (Lei et al. 1987); cpIII(198-406) , part of gene III, encoding the amino acid sequence from residue 198 to 406 (Yanisch-Perron et al., 1985; Barbas III et al., 1991) ; PA, an IgG-binding domain of protein A (Uhlen et al., 1984) ; CH1, gene encoding the CH1 domain of mouse IgG1; Cκ, gene encoding the mouse Cκ domain. 363 saline (PBS). After four rounds of panning, phagemid DNAs were prepared, digested with SalI, self-ligated and transduced into Escherichia coli DH12S and the host cells were plated. These treatments converted phage-display Abs into protein A domain-fused Abs, as described previously . We picked 20 and 19 independent colonies from the plates for cortisol-BSA and 17-OHP-BSA, respectively, and we designated the clones aC1 through aC20 and aH1 through aH19, respectively. The nucleotide sequences of the clones were determined by the dideoxy chain-termination method (Sanger et al., 1977) .
Expression of Fab-PP forms of Abs
Plasmid pFA-E9HL that encoded w1E9 (wild-type 1E9) and 35 clones that encoded protein A domain-fused forms of Abs, aC1 through aC20 and aH1 through aH19, excluding aC4, aC12, aC20 and aH9, were cultured and periplasmic fractions were prepared after induction with isopropyl-β-D-thiogalactopyranoside (IPTG) as described previously . Since all the clones expressed Fab forms of Abs in periplasmic fractions at almost equal amounts that were detected by antiFab antibodies in the Western blotting, these fractions were used for enzyme-linked immunosorbent assay (ELISA). Conditions for ELISA were as follows. Immunoplates were coated with 100 µl of a solution of 17-OHP-BSA or CS-BSA in PBS diluted to an absorbance of 0.002 at 250 nm, and blocked with 0.5% ovalbumin (OVA) in PBS. Then periplasmic extracts, diluted 20-fold with PBS that contained 0.02% Tween 20, were added to the plates. The binding of Fab-PP to the antigens was detected by incubation with rabbit IgG against mouse F(abЈ) 2 and then with alkaline phosphatase-conjugated Ab against rabbit IgG and p-nitrophenyl phosphate.
Construction of a series of mutant Abs by site-directed mutagenesis
Fragments of 232 bp prepared by digestion of aC19 and aH10 with BamHI and BstPI were inserted independently at the same site in pFA-E9HL. The products were designated aC23 and aH20, respectively. PCR was performed using aC13 and primers E9Bam and E9HBst, aC19 and primers E9Bam and E9HBst, and aC19 and primers E9Bam and E9AFBst, and each resultant product was digested with BamHI and BstPI and inserted into the same site in pFA-E9HL to construct aC21, aC22 or aH21, respectively.
Purification of the Fab-PP form of Abs
Large-scale preparation of four Fab-PPs, namely w1E9, aC22, aH20 and aH21, was performed basically in the same way as described previously , with the exception that we used 17-OHP-BSA-linked Sepharose 4B, prepared by immobilizing 17-OHP-BSA on CNBr-activated Sepharose 4B (Pharmacia) instead of HEL-linked Sepharose. The purified Fab-PPs were analysed by SDS-PAGE and the results indicated that no visible extra band was detected. Kinetic analysis using surface plasmon resonance (SPR) Dissociation and association rate constants of the purified FabPPs for CS-HEL and 17-OHP-HEL were measured with a BIAcore instrument (Pharmacia; Johnsson et al., 1991; Chaiken et al; . When only HEL was immobilized on the sensor chip, no response was observed. Therefore, the responses observed should have reflected the specific interactions of Abs with 17-OHP or CS. CS-HEL or 17-OHP-HEL in PBS (pH 7.45) was immobilized on the sensor chip (CM5; Pharmacia), according to the manufacturer's instructions, by the amine coupling method. Then purified Fab-PPs at 40, 80, 120, 160 and 200 nM were injected into cells. Measurements of SPR were made at a flow rate of 30 µl/min in HBS, which consisted of 10 mM HEPES (pH 7.45), 3.4 mM EDTA, 150 mM NaCl and 0.005% Tween 20, at 25°C. Dissociation rate constants for each concentration of Abs were estimated from sensorgrams in the dissociation phase and those for Abs at 120 nM were taken as the dissociation rate constants, designated k diss . Association rate constants, designated k ass , were evaluated by determination of the slopes of the plots of the slope K s of dR/dt versus R against the concentration of the Ab, according to BIAevaluation 2.0 software. K a was calculated as ratio of k ass to k diss .
Results and discussion
Structural modelling of the 17-OHP-binding site of 1E9
In order to construct a model of the 17-OHP-binding site of 1E9, we searched for an Ab whose Fv sequence was most similar to that of 1E9 and whose structure had been stored in the Brookhaven Protein Data Bank. The amino acid sequence of the AN02 V H domain, which is an anti-dinitrophenyl-spin-label Ab, differs by only 14 residues from that of 1E9, apart from the CDR3. The loop structures formed by CDR1 and CDR2 have been well characterized and were classified into several canonical structures. According to Chothia and Lesk (1987) , amino acids at the 24th, 26th, 27th, 29th, 34th and 94th positions, as well as its length, should be critical for determination of the loop structure formed by CDR1. The amino acids at all these six positions and their length are identical between AN02 and 1E9. The loop structure formed by CDR2 would be determined mainly by its length. AN02 and 1E9 have the same length as CDR2 as indicated in Table I . Since, in the CDR3 regions of AN02 and 1E9, both the amino acid sequences and the lengths differ as indicated in Table I , the structure formed by CDR3 of a progesterone-binding mAb, DB3, was superimposed on the corresponding region of AN02 to make up for the difference. Since the CDR3 shows variability not only in the amino acid sequence but also in its length, it has been difficult to establish relationships between the sequence and the tertiary structure. Recently, however, Shirai et al. (1996) hypothesized several empirical rules that could 364 partly govern the determination of its tertiary structure. According to the rules proposed, while the backbone conformations of the bases of CDR3 fall into two classes-kinked and extendedpresence or absence of a salt bridge formed between Arg at the 94th position and Asp at the 101st position should be one of the key factors. X-Ray analysis of DB3 indicated the presence of the salt bridge, thus, a kinked structure (Arevalo et al., 1993a, b) . In 1E9, Arg and Asp were found at the 94th and 101st position, respectively. The β-hairpin structure was further characterized by presence or absence of an additional bulge. While hydrogen bonds were formed between main chains of Asp at the 96th position and that of Tyr at the 100j position without an additional bulge in DB3, the length of the CDR3 of 1E9 was the same as DB3. We assumed that 17-OHP would bind to 1E9 at a binding site similar to that of progesterone on DB3, in the same orientation. The model is depicted in Figure 3a . It suggested that the conformation of the main chain formed by CDR1 and 2 of 1E9 is essentially the same as that of AN02 and that the conformation of the main chain formed by CDR3 of 1E9 is as that of DB3. According to the model, the A, B and C rings of a steroid might be generally expected to make contact with the L chain and the B, C and D rings to make contact with H chain. Moreover, both the 11-and 21-protons, which are replaced by hydroxy groups in cortisol, could only be located near to the H chain. Y50 and Y100i of the H chain would form a stack with the steroid and would be expected to play an important role in the binding, in the same way as indicated for the interactions between progesterone and Ab DB3 (Arevalo et al., 1993a, b) . This model suggested that changes in amino acids located in the three CDRs of the H chain would be required to achieve a change in specificity from 17-OHP to cortisol.
Design and construction of the library
On the basis of the considerations described above, we designed a library in which three CDRs of only the H chain were diversified. For the choice of target residues and the kinds of amino acids to be inserted, we adopted the following principles in the present study. It appeared that the amino acids at the 50th, 53rd and 100i positions should be aromatic. Thus, we chose Tyr and Phe both as the 50th and 53rd residues, and Tyr and Trp as the 100i residue. We postulated that Trp at the 100i position might form hydrogen bonds with the 11-or 21-hydroxy group of cortisol, and/or that Tyr at the 50th position might have a sterically negative effect on the binding of cortisol because of the presence of the additional hydroxy groups in cortisol. Ile at the 51st position was not changed since it was found in nine Abs specific for derivatives of progesterone. Trp at the 35th and Asn at the 35a position were also left unchanged since they were conserved in four Abs specific for 17-OHP and classified into the V H 3 family. Arg at the 99th position was not mutated since it appeared to be irrelevant for binding of a steroid. The kinds of amino acid at the other positions, from the 31st to the 34th in CDR1; the 49th, 50th, 52nd and 54th in CDR2; and the 96th through 98th and 100j and 100k in CDR3, were chosen on the basis of the following considerations except in a few cases: each of them had to be found at the corresponding position in the nine Abs listed in Table I ; each had to be able to form hydrogen bonds; and each had to be less bulky.
The library was constructed in two steps, as described in Materials and Methods. While the number of theoretically different clones should be 48 in pFCA-E9HlibIL, the actual number of independently transformed clones was 2.5ϫ10 4 . The former number in pFCA-E9HlibIIL was 2.2ϫ10 5 and the latter number was 3.1ϫ10 6 . The final number of independent clones in pFCAE9HlibL was 1.5ϫ10 8 while the number of theoretically different clones was 1.1ϫ10 7 . Thus, we expected that the library should contain all the sequences that could be predicted to exist within it. In order to examine possible bias in diversification of sequence during PCR, we randomly picked 31 clones and Thirty-one clones, picked at random from the library, were sequenced. The frequencies of amino acids found at each position are indicated.
determined their nucleotide sequences. As summarized in Table  II , they were fairly well diversified, as expected, except at the 34th residue.
Characterization of clones isolated by panning with 17-OHPconjugated BSA
After four rounds of panning with 17-OHP-BSA, we isolated and characterized 19 clones. The results of ELISA using protein A domain-fused forms of the Abs (Fab-PP forms) indicated all of them bound 17-OHP as strongly as the wild-type Ab (w1E9), as indicated in Figure 4a , but many of them did not bind cortisol (Figure 4b ). Only aH5 had low cortisol-binding activity. Since all of the clones had different sequences, as indicated in Table III (A), they represented only some of the clones in the population that had 17-OHP-binding activity. However, the amino acid sequences of these 19 clones had various interesting characteristics. In CDR1, Pro and Tyr were not found at the 33rd position, perhaps because of structural requirements for maintenance of the integrity of the immunoglobulin fold and/or because of indirect negative effects on formation of the antigenbinding pocket. The low frequency of Val at the 34th position might simply have reflected the low frequency of Val observed in the total population of the library. There did not seem to be any specific bias with respect to other amino acids at the 31st, 32nd and 33rd positions. These observations appeared to be consistent with the model, which suggested CDR1 did not contribute very much to formation of the 17-OHP-binding pocket.
In CDR2 and CDR3, we observed preferential usage of some specific amino acids at several positions; for example, Gly at the 49th and Asn or Ser at the 96th position. The most notable feature was, however, that the 19 clones seemed to be classifiable into two groups. The first group, clones aH1, aH3, aH9, aH16, aH18 and aH19, had a sequence identical to that of the wild type. The 13 clones in the second group had several mutations. While aH8 had three mutations, the other 12 clones had from five to nine mutations. We found no clone that had only one or two mutations in CDR2 and CDR3. Although the number of clones that we analysed was not very large, this observation might be statistically meaningful. Moreover, the first group had Val at position 100j and the second group had Ala at this position without exception. According to the model, the amino acid at this site 366 forms part of the bottom of the 17-OHP-binding pocket and is located in the vicinity of N96, S97, R99, Y100i and M100k of the H chain and the D ring of 17-OHP. This result suggested that the deletion of two methyl groups in the replacement of Val by Ala might have a major influence on the overall structure of the 17-OHP-binding pocket. Thus, to reorganize the binding pocket in the presence of Ala at position 100j, several amino acids must be changed simultaneously from those in the wild type. The mutations in CDR2 and CDR3 in the second group allowed 
The sequences of aC4 and aC20 were identical to that of clone aC1 and the sequence of aC12 was identical to that of aC8. -, The same amino acid as that in w1E9.
variations. By contrast, in the first group, no mutations in these regions were acceptable.
Characterization of clones isolated by panning with cortisolconjugated BSA
Twenty clones with cortisol-binding ability were also isolated from the library by the panning method. As shown in Figure 4 , all of them bound both cortisol and 17-OHP. Since both series of clones, namely, aH1 though aH19 (aH) and aC1 through aC20 (aC), had 17-OHP-binding ability, isolated aH clones might not have shown cortisol-binding ability simply because of differ-367 ences in the number of clones of both types examined. The number of clones that bound only 17-OHP should have been much larger than that of the clones that bound both cortisol and 17-OHP. The aH clones were classified into two groups, as described above, but all the aC clones appeared to be derived from the second group with Ala at the 100j position [Table III(B)] . Moreover, the amino acid sequences of the aC clones appeared to be more restricted than those of the aH clones. It was reasonable that all of the aC clones had been derived from the second group of aH clones because they all had strong binding affinity for 17- 
The same amino acid as that in w1E9. OHP and several mutations in CDR2 and CDR3. The most commonly observed amino acids in regions of interest in the aC clones were Thr-Phe-Asn at the 52nd to 54th and Tyr-Ala-Met at the 100ijk positions. Arg at the 98th position also seemed to be preferable. Among them, amino acids at the 100ijk positions were directly involved in the antigen-binding pocket, according to the model, while those at the 52nd to 54th positions were not directly involved but were located in regions that surrounded the amino acids that formed the pocket. Therefore, even if they were not directly involved in formation of the binding pocket, they should have had a major influence on its overall structure.
Characterization of clones generated by site-directed mutagenesis
In order to examine which residue might be most critical for the change from the second group of aH Abs to aC Abs, we constructed several mutant Abs by site-directed mutagenesis. While Thr-Phe-Asn at the 52nd to 54th positions were found in three aH Abs, Phe was found at the 100k position instead of Met in all cases. In five cases of aC Abs, one amino acid was replaced in the Thr-Phe-Asn sequence at the 52nd to 54th positions. However changes at other positions might have compensated to allow accommodation of cortisol as the antigen. Thus, we chose the 48th, 52nd, 53rd and 100k residues as targets for mutation and constructed several more Abs, as summarized in Table IV . The results of ELISA are indicated in Figure 4 . Val and Met at the 48th position did not seem to have any effect on the binding activity. While we assumed that Thr-Phe-Asn at the 52nd to 54th positions, as well as Met at the 100k position (aC22), were standard for the cortisolbinding pocket, a change at the 53rd position from Phe to Tyr (aC21) did not alter the cortisol-binding activity. By contrast, a change at the 52nd position from Thr to Asn (aH20), as well as a change at the 100k position from Met to Phe (aH21), resulted in the loss of cortisol-binding activity. Thus, even a 368 single point mutation had a dramatic effect on the ability to bind cortisol.
Kinetic analysis of antigen-antibody interactions
In the previous section, we showed that even a single point mutation could have a major effect on cortisol-binding activity. In order to examine the rules that determined antigen specificity, we analysed the Ag-Ab interactions kinetically using representative clones. The association rate constant and the dissociation rate constant of Abs w1E9, aC22, aH20 and aH21 with 17-OHP were measured with the BIAcore apparatus. While we used the BSA-conjugated Ags in the above ELISA experiments, the BSA-conjugated Ags could not be well immobilized on the sensor chip probably because the same amino groups located on the surface of BSA should have been involved in the amine coupling of both conjugation and immobilization. Since the number of amino groups on the surface of HEL was expected to be larger than that of BSA, we conjugated Ags with HEL and used them for the BIAcore analysis. There were no very big differences in the respective values of k ass and k diss and, thus, in K a among the four Abs, as indicated in Table V . However, the K a for aC22 with cortisol was one order of magnitude higher than those of the other three Abs. These results were consistent with those obtained by ELISA. The high affinity of aC22 for cortisol appeared to be due mainly to an increase in the on-rate constant. The phenomenon that a change in affinity was caused by an increase in the on-rate constant appeared to be quite different from our previous observations that indicated that mutations in the CDRs do not result in large differences in the on-rate constant of the complex formation between an Ab and an Ag (Ito et al., 1995) . Major differences between the previous experiment and the present experiment might be based on differences in the nature of the interactions. In the present experiment, a small hapten, cortisol, was bound in the binding pocket formed by the Ab. In the previous experiment where HEL formed a complex with an Ab, the interactions occurred between the surface of the HEL and the surface of the Ab and, thus, mutations in the CDRs did not have a major effect on the association constant (Ito et al., 1995) . Similar observations have been reported by other investigators (Foote and Winter, 1992; England et al., 1997) . However, there has been an example where, in the interactions between Abs and protein Ags, the differences in the affinity constants were caused mainly by changes in the on-rate constants (Braden et al., 1996) . Relationships between antigen specificity and the structure of the antigen-binding pocket, as predicted from models Models of complexes of w1E9, aC22, aH20 and aH21 with cortisol were constructed as described in Materials and methods. According to the models, it was only in the case of aC22 among the Abs analysed, that an amino group of the side chain of R56 in the H chain appeared to be located near the 11-hydroxy group of cortisol (Figure 3b ). In the other cases, such an amino group seemed to be located far from cortisol (data not shown). Moreover, the ε-nitrogen atom of R56 of aC22 appeared to be located near both the hydroxy group of the side chain of T52 and the amino group of the side chain of N54 in the H chain. By contrast, side chains of R56 in the H chains of the other clones seemed to be located at a distance from side chains of the 52nd and 54th residues in the H chain. If these predictions are valid, interactions between polar groups, such as hydrogen bonds, might occur among these residues and cortisol, which could contribute to the binding of cortisol. From our models and experimental results, the following explanations can be proposed. (i) The w1E9 and aH Abs have low cortisol-binding activity because cortisol cannot fit as easily as 17-OHP into their binding pockets. (ii) Even if cortisol cannot fit as easily as 17-OHP in the original binding pocket of aC22, the aC22 and aC Abs have high cortisol-binding activity as a result of compensation via interaction of cortisol with the side chain of R56, whose orientation has been determined by attraction caused by side chains of T52 and N54. (iii) aH20 and aH21 might have had low cortisol-binding activity, despite differing only in one residue from aC22, because the side chain of R56 cannot participate in binding of cortisol. An analysis of the various complexes by X-ray crystallography or NMR would be required to validate these explanations. Perspective In the present study, we attempted to change the specificity of Abs using mAb 1E9, which is specific for 17-OHP. First, we built a model of the 17-OHP-binding pocket. On the basis of this model, we constructed a library composed of many different Abs in which 16 residues in the three CDRs of the H chain, possibly involved in formation of the Ag-binding pocket, were mutated. Since we attempted to change a 17-OHP-binding Ab to a cortisol-binding Ab, the most critical residues for binding of steroid rings, such as the 50th and 100i residues, were not changed to any great extent. After selection of clones by panning, we isolated 19 clones that retained 17-OHP-binding ability and 20 with newly developed ability to bind cortisol, respectively. The results indicated that there seemed to be two groups in terms of the kind of 17-OHPbinding pocket, one that did not tolerate mutations and one that tolerated mutations in CDR2 and CDR3. The cortisolbinding clones were derived from the second group. Although 369 we did not succeed in isolating the clones that bound only cortisol, and not 17-OHP as well, the strategy that we adopted in this study might provide a general method for changing antigen specificity. It appears that it will be difficult to change antigen specificity by changing only a few residues by sitedirected mutagenesis. As described in this paper, a new binding pocket can be generated by introduction of simultaneous mutations at many sites. The results obtained could not have been predicted by computer modelling alone. Further finetuning of the pocket is required to exclude binding of 17-OHP without loss of the ability to bind cortisol. Such a two-step strategy should be considered for a 'real' change in Ag specificity. The actual process will require two rounds of mutation and selection, the first to convert the 17-OHP-specific Ab to both an 17-OHP-and cortisol-specific Ab, and the second to convert the 17-OHP-and cortisol-specific Ab to an exclusively cortisol-specific Ab. The latter step should be possible using basically the same strategy as described in this paper. Isolation of such clones will require competition between the target antigen and the original antigen during the panning procedure. Such experiments should help us to understand the meaning of differences in on-rate constants at the molecular level.
